2020-2025 Global Supportive Care in Oncology Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Care given to expand the quality of life of patients who have a serious or severe disease. The goal of supportive care is to prevent or treat as early as possible the symptoms of a disease, side effects caused by treatment of a disease, and psychological, social, and spiritual problems related to a disease or its treatment. Also called comfort care, palliative care and symptom management. The Supportive Care Centre accepts patients of all cancer diagnoses, at any point within their disease and/or treatment process. It’s involves in care of physical or emotional symptoms, improving function and reducing disability.
This report elaborates the market size, market characteristics, and market growth of the Supportive Care in Oncology industry, and breaks down according to the type, application, and consumption area of Supportive Care in Oncology. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Supportive Care in Oncology in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Supportive Care in Oncology market covered in Chapter 13:
Baxter International Inc
Hoffmann LA- Roche Ltd
Kyowa Hakko Kirin Co Ltd.
Johnson & Johnson
Acacia Pharma Ltd.
Amgen Inc.
Fagron Group BV
Novartis Ag.
Teva Pharmaceuticals Industries Ltd
APR Applied Pharma Science Research S.A.

In Chapter 6, on the basis of types, the Supportive Care in Oncology market from 2015 to 2025 is primarily split into:
Opioid analgesics
Nonsteroidal erythropoietin stimulating agents
Anti-infective drugs
Anti-imflammatory drugs
Bisphosphonates
Monoclonal antibodies
Anti-emetics drugs
Granulocyte colony stimulating factor

In Chapter 7, on the basis of applications, the Supportive Care in Oncology market from 2015 to 2025 covers:
Lung cancer
Prostate cancer
Breast cancer
Ovarian cancer
Leukemia
Bladder cancer
Liver cancer
Melanoma
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025